A phase I clinical trial on the safety and efficacy of ProSavin® a dopamine replacement gene therapy for Parkinson's disease (PD): An interim report

被引：0
|
作者：
Jarraya, B.
Lepetit, H.
Ralph, S.
Miskin, J.
Gurruchaga, J. -M.
Vinti, M.
Fenelon, G.
Brugieres, P.
Abhay, K.
Gabriel, I.
Boulet, S.
Jan, C.
Kingsman, S.
Cesaro, P.
Hantraye, P.
Remy, P.
Mitrophanous, K.
Palfi, S.
机构：
来源：
MOVEMENT DISORDERS | 2010年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
249
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [1] ProSavin® a Dopamine Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial
    Palfi, S.
    Gurruchaga, J. -M.
    Ralph, G. S.
    Watts, C.
    Buttery, P.
    Scorer, S.
    Lepetit, H.
    Miskin, J.
    Iwamuro, H.
    Lavisse, S.
    Kas, A.
    Ramelli, A. L.
    Tani, N.
    Dolphin, P.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Naylor, S.
    Hantraye, P.
    Remy, P.
    Barker, R.
    Mitrophanous, K.
    CELL TRANSPLANTATION, 2013, 22 (05) : 911 - 911
  • [2] A phase I/II clinical trial to evaluate the safety and efficacy of ProSavin®, a gene therapy approach for Parkinson's disease
    Jarraya, B.
    Lepetit, H.
    Ralph, S.
    Boulet, S.
    Jan, C.
    Bonvento, G.
    Miskin, J.
    Gurruchaga, J. -M.
    Vinti, M.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Hantraye, P.
    Remy, P.
    Mitrophanous, K.
    Palfi, S.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S145 - S145
  • [3] ProSavin® a Gene Therapy Approach for Parkinson's Disease: Phase I Clinical Trial Update
    Palfi, Stephane
    Watts, Colin
    Gurrachaga, Jean-Marc
    Buttery, Philip
    Ralph, Scott
    Deeley, Saray
    Lepetit, Helene
    Miskin, James
    Iwamuro, Hirokazu
    Lavisse, Sonia
    Kas, Aurelie
    Ramelli, Anne Laure
    Tani, Naoki
    Dolphin, Patrice
    Abhay, K.
    Gabriel, I.
    Fenelon, Gilles
    Brugiere, Pierre
    Naylor, Stuart
    Hantraye, Philippe
    Remy, Philippe
    Barker, Roger
    Mitrophanous, Kyriacos
    MOLECULAR THERAPY, 2012, 20 : S23 - S23
  • [4] ProSavin® a Gene Therapy Approach for Parkinson Disease: Phase I Clinical Trial Update
    Palfi, S.
    Jarraya, B.
    Gurruchaga, J-M
    Ralph, S.
    Lepetit, H.
    Lavisse, S.
    Miskin, J.
    Kas, A.
    Fenelon, S.
    Brugiere, P.
    Kingsman, S.
    Naylor, S.
    Hantraye, P.
    Remy, K.
    Mitrophanous, K.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1364 - 1364
  • [5] ProSavin® a gene therapy approach for the treatment of Parkinson's Disease: a Phase I Clinical Trial Update
    Palfi, Stephane
    Watts, Collin
    Marc, Gurruchaga Jean
    Peter, Buttery
    Scott, Ralph
    Sarah, Deeley
    Helene, Lepetit
    James, Miskin
    Hiro, Iwamuro
    Sonia, Lavisse
    Aurelie, Kas
    Laure, Ramelli Anne
    Naoki, Tani
    Gilles, Fenelon
    Pierre, Brugie're
    Stuart, Naylor
    Philippe, Hantraye
    Philippe, Remy
    Roger, Barker
    Kyriacos, Mitrophanous
    HUMAN GENE THERAPY, 2012, 23 (10) : A61 - A61
  • [6] ProSavin® a Gene Therapy Approach for the Treatment of Parkinson's Disease: Phase I Clinical Trial Update
    Palfi, S.
    Gurruchaga, J-M
    Scorer, S.
    Ralph, S.
    Lepetit, H.
    Jarraya, B.
    Miskin, J.
    Iwamuro, H.
    Lavisse, S.
    Ramelli, A. L.
    Tani, N.
    Dolphin, P.
    Abhay, K.
    Gabriel, I.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Price, G.
    Naylor, S.
    Hantraye, P.
    Remy, P.
    Mitrophanous, K.
    HUMAN GENE THERAPY, 2011, 22 (10) : A20 - A20
  • [7] Prosavin, a dopamine gene therapy for advanced PD: phase I clinical update
    Palfi, S.
    Gurruchaga, J-M.
    Ralph, G. S.
    Watts, C.
    Buttery, P.
    Scorer, S.
    Lepetit, H.
    Miskin, J.
    Iwamuro, H.
    Lavisse, S.
    Kas, A.
    Ramelli, A. L.
    Tani, N.
    Dolphin, P.
    Fenelon, G.
    Brugiere, P.
    Kingsman, S.
    Naylor, S.
    Barker, R.
    Hantraye, P.
    Remy, P.
    Cesaro, P.
    Mitrophanous, K.
    NEUROREPORT, 2014, 25 (03) : 147 - 147
  • [8] Prosavin®, a dopamine gene therapy for advanced Parkinson's disease: 5 years phase I/II clinical update
    Palfi, S.
    Gurruchaga, J. M.
    Watts, C.
    Buttery, P. C.
    Lepetit, H.
    Fenelon, G.
    Binley, K.
    Howard, K.
    Lad, Y.
    Tuckwell, N. J.
    Hantraye, P.
    Barker, R. A.
    Mitrophanous, K. A.
    HUMAN GENE THERAPY, 2018, 29 (12) : A87 - A87
  • [9] ProSavin: A gene therapy for Parkinson's Disease
    Jarraya, Bechir
    Ralph, Scott
    Lepetit, Helene
    Boulet, Sabrina
    Jan, Caroline
    Bonvento, Gilles
    Azzouz, Mimoun
    Miskin, James
    Gurruchaga, Jean Marc
    Palfi, Stephane
    Fenelon, Gilles
    Brugiere, Pierre
    Day, Debbie
    Kingsman, Susan
    Hantraye, Philippe
    Remy, Philippe
    Mitrophanous, Kyriacos
    Mazarakis, Nickolas
    Palfi, Stephane
    HUMAN GENE THERAPY, 2008, 19 (10) : 1060 - 1061
  • [10] ProSavin a gene therapy approach for Parkinson's disease
    Jarraya, Bechir
    Lepitit, Helene
    Ralph, Scott
    Tani, Naoki
    Boulet, Sabrina
    Jan, Caroline
    Bonvento, Gilles
    Miskin, James
    Gurruchaga, Jean-Marc
    Vinti, Maria
    Fenelon, Gilles
    Brugiere, Pierre
    Kingsman, Susan
    Hantraye, Philippe
    Remy, Philippe
    Mitrophanous, Kyriacos
    Palfi, Stephane
    HUMAN GENE THERAPY, 2009, 20 (11) : 1391 - 1392
12345